Symbols / KURA $9.53 +0.63% Kura Oncology, Inc.

Healthcare • Biotechnology • United States • NMS
KURA Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.

Fundamentals
Scroll to Statements
Market Cap 845.91M Enterprise Value 189.70M Income -278.67M Sales 67.48M Book/sh 1.98 Cash/sh 7.55
Dividend Yield — Payout 0.00% Employees 260 IPO — P/E — Forward P/E -3.80
PEG — P/S 12.54 P/B 4.81 P/C — EV/EBITDA -0.63 EV/Sales 2.81
Quick Ratio 5.81 Current Ratio 6.06 Debt/Eq 11.75 LT Debt/Eq — EPS (ttm) -3.18 EPS next Y -2.51
EPS Growth — Revenue Growth -67.80% Earnings 2026-05-07 ROA -25.33% ROE -94.82% ROIC —
Gross Margin -272.14% Oper. Margin -4.98% Profit Margin 0.00% Shs Outstand 88.76M Shs Float 64.88M Short Float 16.43%
Short Ratio 9.31 Short Interest — 52W High 12.49 52W Low 5.45 Beta 0.24 Avg Volume 1.49M
Volume 968.55K Target Price $31.17 Recom Strong_buy Prev Close $9.47 Price $9.53 Change 0.63%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$31.17
Mean price target
2. Current target
$9.53
Latest analyst target
3. DCF / Fair value
$-28.74
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.53
Low
$15.00
High
$76.00
Mean
$31.17

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-14 init Lake Street — → Buy $23
2026-03-24 main Mizuho Outperform → Outperform $25
2026-03-13 main UBS Buy → Buy $15
2026-03-06 main Wedbush Outperform → Outperform $36
2026-01-13 main Leerink Partners Outperform → Outperform $20
2026-01-13 reit HC Wainwright & Co. Buy → Buy $40
2025-11-24 main Barclays Overweight → Overweight $28
2025-11-14 main UBS Buy → Buy $16
2025-11-14 main Wedbush Outperform → Outperform $38
2025-10-20 reit JMP Securities Market Outperform → Market Outperform $24
2025-10-20 reit HC Wainwright & Co. Buy → Buy $40
2025-09-30 reit HC Wainwright & Co. Buy → Buy $40
2025-09-04 init Guggenheim — → Neutral —
2025-08-11 main JMP Securities Market Outperform → Market Outperform $24
2025-06-26 reit Cantor Fitzgerald Overweight → Overweight —
2025-06-20 reit Wedbush Outperform → Outperform $36
2025-06-04 reit JMP Securities Market Outperform → Market Outperform $28
2025-05-19 main Mizuho Outperform → Outperform $30
2025-05-02 main Barclays Overweight → Overweight $11
2025-04-29 reit JMP Securities Market Outperform → Market Outperform $28
News
RSS: Latest KURA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-23 WILSON TROY EDWARD Chief Executive Officer — 6,103 $6.15 $37,533
2026-03-18 MALLEY THOMAS ROBERT Director — 10,000 $3.12 $31,200
2026-01-27 FORD KATHLEEN Chief Operating Officer — 1,813 $8.46 $15,339
2026-01-27 BAIR TERESA BROPHY Officer — 11,208 $8.46 $94,828
2026-01-27 DOYLE THOMAS JAMES Officer — 7,142 $8.46 $60,426
2026-01-27 POWL BRIAN T Officer — 6,414 $8.46 $54,266
2026-01-27 LEONI MOLLIE M.D. Officer — 8,180 $8.46 $69,209
2026-01-27 BURROWS FRANCIS J. PH.D. Officer — 1,311 $8.46 $11,092
2026-01-02 FORD KATHLEEN Chief Operating Officer — 50,000 $0.00 $0
2026-01-02 BAIR TERESA BROPHY Officer — 50,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
67.48
+25.24%
53.88
0.00
0.00
Operating Revenue
67.48
+25.24%
53.88
0.00
0.00
Cost Of Revenue
0.06
0.00
0.00
—
Reconciled Cost Of Revenue
0.06
0.00
0.00
—
Gross Profit
67.42
+25.13%
53.88
0.00
—
Operating Expense
371.06
+50.18%
247.08
+49.02%
165.80
+18.55%
139.87
Research And Development
251.07
+47.72%
169.97
+47.50%
115.23
+24.16%
92.81
Selling General And Administration
119.98
+55.60%
77.11
+52.49%
50.57
+7.47%
47.05
General And Administrative Expense
119.98
+55.60%
77.11
+52.49%
50.57
+7.47%
47.05
Other Gand A
119.98
+55.60%
77.11
+52.49%
50.57
+7.47%
47.05
Total Expenses
371.11
+50.20%
247.08
+49.02%
165.80
+18.55%
139.87
Operating Income
-303.63
-57.16%
-193.19
-16.52%
-165.80
-18.55%
-139.87
Total Operating Income As Reported
-303.63
-57.16%
-193.19
-16.52%
-165.80
—
EBITDA
-275.82
-62.73%
-169.50
-12.82%
-150.23
-11.41%
-134.85
Normalized EBITDA
-275.82
-62.73%
-169.50
-12.82%
-150.23
-11.41%
-134.85
Reconciled Depreciation
1.03
+21.70%
0.85
-0.12%
0.85
+11.86%
0.76
EBIT
-276.86
-62.53%
-170.35
-12.75%
-151.08
-11.41%
-135.61
Net Income
-278.67
-60.17%
-173.98
-13.99%
-152.63
-12.36%
-135.84
Pretax Income
-278.37
-61.88%
-171.97
-12.67%
-152.63
-12.36%
-135.84
Net Non Operating Interest Income Expense
25.26
+18.99%
21.23
+61.16%
13.17
+227.28%
4.03
Interest Expense Non Operating
1.51
-6.61%
1.62
+4.52%
1.55
+576.42%
0.23
Net Interest Income
25.26
+18.99%
21.23
+61.16%
13.17
+227.28%
4.03
Interest Expense
1.51
-6.61%
1.62
+4.52%
1.55
+576.42%
0.23
Interest Income Non Operating
26.77
+17.18%
22.85
+55.20%
14.72
+246.07%
4.25
Interest Income
26.77
+17.18%
22.85
+55.20%
14.72
+246.07%
4.25
Tax Provision
0.30
-85.28%
2.02
0.00
0.00
Tax Rate For Calcs
0.00
+0.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-278.67
-60.17%
-173.98
-13.99%
-152.63
-12.36%
-135.84
Net Income From Continuing Operation Net Minority Interest
-278.67
-60.17%
-173.98
-13.99%
-152.63
-12.36%
-135.84
Net Income From Continuing And Discontinued Operation
-278.67
-60.17%
-173.98
-13.99%
-152.63
-12.36%
-135.84
Net Income Continuous Operations
-278.67
-60.17%
-173.98
-13.99%
-152.63
-12.36%
-135.84
Normalized Income
-278.67
-60.17%
-173.98
-13.99%
-152.63
-12.36%
-135.84
Net Income Common Stockholders
-278.67
-60.17%
-173.98
-13.99%
-152.63
-12.36%
-135.84
Diluted EPS
-3.18
-57.43%
-2.02
+2.88%
-2.08
-2.46%
-2.03
Basic EPS
-3.18
-57.43%
-2.02
+2.88%
-2.08
-2.46%
-2.03
Basic Average Shares
87.68
+1.76%
86.16
+17.66%
73.23
+9.31%
66.99
Diluted Average Shares
87.68
+1.76%
86.16
+17.66%
73.23
+9.31%
66.99
Diluted NI Availto Com Stockholders
-278.67
-60.17%
-173.98
-13.99%
-152.63
-12.36%
-135.84
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
738.36
-2.87%
760.16
+69.32%
448.94
-1.62%
456.31
Current Assets
708.66
-4.86%
744.83
+72.22%
432.48
-3.12%
446.43
Cash Cash Equivalents And Short Term Investments
667.24
-8.27%
727.39
+71.57%
423.96
-3.20%
437.99
Cash And Cash Equivalents
149.10
-33.57%
224.46
+501.48%
37.32
-27.96%
51.80
Cash Equivalents
—
200.02
+1371.85%
13.59
-71.59%
47.83
Cash Financial
—
24.44
+2.99%
23.73
+497.98%
3.97
Other Short Term Investments
518.14
+3.02%
502.93
+30.08%
386.64
+0.12%
386.18
Receivables
8.80
+327.38%
2.06
—
—
Accounts Receivable
8.80
+327.38%
2.06
—
—
Inventory
0.41
0.00
—
—
Prepaid Assets
—
—
—
—
Other Current Assets
32.21
+109.48%
15.37
+80.36%
8.52
+0.98%
8.44
Total Non Current Assets
29.70
+93.74%
15.33
-6.83%
16.45
+66.54%
9.88
Net PPE
15.16
+102.50%
7.49
-15.44%
8.85
+38.70%
6.38
Gross PPE
18.06
+67.82%
10.76
-4.81%
11.30
+41.57%
7.99
Accumulated Depreciation
-2.90
+11.45%
-3.27
-33.56%
-2.45
-52.96%
-1.60
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
3.84
+19.35%
3.21
+16.11%
2.77
+6.46%
2.60
Other Properties
7.30
+25.83%
5.80
-17.02%
6.99
+82.01%
3.84
Leases
6.92
+296.96%
1.74
+12.96%
1.54
+0.00%
1.54
Other Non Current Assets
14.54
+85.38%
7.84
+3.20%
7.60
+117.32%
3.50
Total Liabilities Net Minority Interest
564.23
+62.83%
346.52
+570.74%
51.66
+43.39%
36.03
Current Liabilities
116.97
+48.61%
78.71
+123.21%
35.26
+46.58%
24.06
Payables And Accrued Expenses
44.34
+36.67%
32.45
+57.47%
20.60
+80.12%
11.44
Payables
5.26
+48.90%
3.53
+53.48%
2.30
+50.03%
1.53
Accounts Payable
5.02
+241.52%
1.47
-36.13%
2.30
+50.03%
1.53
Current Accrued Expenses
39.09
+35.18%
28.91
+57.97%
18.30
+84.78%
9.91
Pensionand Other Post Retirement Benefit Plans Current
22.37
+27.78%
17.51
+33.11%
13.15
+27.70%
10.30
Total Tax Payable
0.24
-88.40%
2.06
0.00
—
Income Tax Payable
0.24
-88.40%
2.06
0.00
—
Current Debt And Capital Lease Obligation
1.28
-71.55%
4.49
+198.01%
1.51
-35.03%
2.32
Current Debt
—
2.61
—
—
Other Current Borrowings
—
2.61
—
—
Current Capital Lease Obligation
1.28
-32.11%
1.88
+24.90%
1.51
-35.03%
2.32
Current Deferred Liabilities
48.98
+101.82%
24.27
0.00
—
Current Deferred Revenue
48.98
+101.82%
24.27
0.00
—
Total Non Current Liabilities Net Minority Interest
447.25
+67.01%
267.81
+1533.07%
16.40
+36.99%
11.97
Long Term Debt And Capital Lease Obligation
19.18
+58.43%
12.11
-22.86%
15.69
+34.07%
11.71
Long Term Debt
9.71
+40.41%
6.92
-25.89%
9.33
+1.90%
9.16
Long Term Capital Lease Obligation
9.47
+82.45%
5.19
-18.42%
6.36
+149.69%
2.55
Non Current Deferred Liabilities
424.91
+67.35%
253.91
0.00
—
Non Current Deferred Revenue
424.91
+67.35%
253.91
0.00
—
Other Non Current Liabilities
3.17
+76.32%
1.79
+154.61%
0.70
+166.04%
0.27
Stockholders Equity
174.13
-57.90%
413.64
+4.12%
397.27
-5.47%
420.28
Common Stock Equity
174.13
-57.90%
413.64
+4.12%
397.27
-5.47%
420.28
Capital Stock
0.01
+12.50%
0.01
+14.29%
0.01
+0.00%
0.01
Common Stock
0.01
+12.50%
0.01
+14.29%
0.01
+0.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
87.86
+12.30%
78.23
+5.22%
74.35
+8.84%
68.31
Ordinary Shares Number
87.86
+12.30%
78.23
+5.22%
74.35
+8.84%
68.31
Additional Paid In Capital
1,347.19
+2.97%
1,308.29
+16.81%
1,119.98
+12.32%
997.11
Retained Earnings
-1,174.09
-31.12%
-895.42
-24.12%
-721.44
-26.83%
-568.81
Gains Losses Not Affecting Retained Earnings
1.02
+34.03%
0.76
+160.11%
-1.27
+84.18%
-8.03
Other Equity Adjustments
1.02
+34.03%
0.76
+160.11%
-1.27
+84.18%
-8.03
Total Equity Gross Minority Interest
174.13
-57.90%
413.64
+4.12%
397.27
-5.47%
420.28
Total Capitalization
183.85
-56.29%
420.56
+3.43%
406.61
-5.32%
429.44
Working Capital
591.69
-11.17%
666.12
+67.70%
397.22
-5.95%
422.37
Invested Capital
183.85
-56.55%
423.16
+4.07%
406.61
-5.32%
429.44
Total Debt
20.46
+23.28%
16.59
-3.52%
17.20
+22.65%
14.02
Capital Lease Obligations
10.75
+51.97%
7.07
-10.13%
7.87
+61.69%
4.87
Net Tangible Assets
174.13
-57.90%
413.64
+4.12%
397.27
-5.47%
420.28
Tangible Book Value
174.13
-57.90%
413.64
+4.12%
397.27
-5.47%
420.28
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-64.06
-147.69%
134.32
+207.61%
-124.82
-13.41%
-110.06
Cash Flow From Continuing Operating Activities
-64.06
-147.69%
134.32
+207.61%
-124.82
-13.41%
-110.06
Net Income From Continuing Operations
-278.67
-60.17%
-173.98
-13.99%
-152.63
-12.36%
-135.84
Depreciation Amortization Depletion
1.03
+21.70%
0.85
-0.12%
0.85
+11.86%
0.76
Depreciation
1.03
+21.70%
0.85
-0.12%
0.85
+11.86%
0.76
Depreciation And Amortization
1.03
+21.70%
0.85
-0.12%
0.85
+11.86%
0.76
Other Non Cash Items
0.52
-1.53%
0.52
+9.64%
0.48
+553.42%
0.07
Stock Based Compensation
37.11
+9.47%
33.90
+20.71%
28.08
+6.70%
26.32
Operating Gains Losses
—
—
—
—
Change In Working Capital
184.44
-35.55%
286.17
+3559.97%
7.82
+362.21%
-2.98
Change In Receivables
-6.74
-227.38%
-2.06
0.00
—
Changes In Account Receivables
-6.74
-227.38%
-2.06
0.00
—
Change In Inventory
-0.41
0.00
0.00
—
Change In Prepaid Assets
-15.95
-132.85%
-6.85
-249.49%
-1.96
+33.22%
-2.94
Change In Payables And Accrued Expense
17.15
+12.85%
15.20
+47.19%
10.33
+1387.66%
-0.80
Change In Accrued Expense
12.65
-24.80%
16.83
+49.56%
11.25
—
Change In Payable
4.50
+376.52%
-1.63
-76.08%
-0.92
-15.21%
-0.80
Change In Account Payable
4.50
+376.52%
-1.63
-76.08%
-0.92
-15.21%
-0.80
Change In Other Working Capital
195.72
-29.64%
278.18
—
—
Change In Other Current Assets
-6.36
-771.91%
0.95
+238.25%
-0.69
-219.96%
0.57
Change In Other Current Liabilities
1.04
+37.60%
0.76
+453.28%
0.14
-25.54%
0.18
Investing Cash Flow
-13.10
+87.11%
-101.59
-753.02%
15.56
-52.32%
32.63
Cash Flow From Continuing Investing Activities
-13.10
+87.11%
-101.59
-753.02%
15.56
-52.32%
32.63
Net PPE Purchase And Sale
-6.64
-1306.36%
-0.47
-180.95%
-0.17
+73.16%
-0.63
Purchase Of PPE
-6.64
-1306.36%
-0.47
-180.95%
-0.17
+73.16%
-0.63
Capital Expenditure
-6.64
-1306.36%
-0.47
-180.95%
-0.17
+73.16%
-0.63
Net Investment Purchase And Sale
-6.46
+93.61%
-101.12
-743.04%
15.72
-52.71%
33.25
Purchase Of Investment
-761.59
-15.56%
-659.05
-60.81%
-409.82
-51.42%
-270.65
Sale Of Investment
755.13
+35.34%
557.93
+31.11%
425.55
+40.03%
303.91
Financing Cash Flow
1.79
-98.84%
154.42
+62.92%
94.78
+145.77%
38.56
Cash Flow From Continuing Financing Activities
1.79
-98.84%
154.42
+62.92%
94.78
+145.77%
38.56
Net Issuance Payments Of Debt
—
0.00
0.00
-100.00%
10.00
Issuance Of Debt
—
0.00
0.00
-100.00%
10.00
Repayment Of Debt
—
—
0.00
0.00
Long Term Debt Issuance
—
0.00
0.00
-100.00%
10.00
Long Term Debt Payments
—
—
0.00
0.00
Net Long Term Debt Issuance
—
0.00
0.00
-100.00%
10.00
Net Common Stock Issuance
0.00
-100.00%
145.81
+55.82%
93.58
+278.53%
24.72
Proceeds From Stock Option Exercised
1.79
-79.16%
8.60
+613.43%
1.21
-72.71%
4.42
Net Other Financing Charges
—
—
—
-0.57
Changes In Cash
-75.36
-140.27%
187.14
+1392.07%
-14.48
+62.74%
-38.87
Beginning Cash Position
224.46
+501.48%
37.32
-27.96%
51.80
-42.87%
90.67
End Cash Position
149.10
-33.57%
224.46
+501.48%
37.32
-27.96%
51.80
Free Cash Flow
-70.70
-152.82%
133.84
+207.08%
-124.99
-12.92%
-110.69
Interest Paid Supplemental Data
1.00
-8.94%
1.10
+3.01%
1.06
+1357.53%
0.07
Amortization Of Securities
-8.49
+35.41%
-13.14
-39.50%
-9.42
-685.09%
1.61
Common Stock Issuance
0.00
-100.00%
145.81
+55.82%
93.58
+278.53%
24.72
Issuance Of Capital Stock
0.00
-100.00%
145.81
+55.82%
93.58
+278.53%
24.72
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category